/C O R R E C T I O N -- NRx Pharmaceuticals, Inc./ PR Newswire RADNOR, Pa., Feb. 27, 2024 In the news release...
NRx Pharmaceuticals, Inc. Announces Pricing of $1.5 Million Underwritten Public Offering of Common Stock...
NRx Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Common Stock PR Newswire RADNOR...
NRx Pharmaceuticals (Nasdaq:NRXP) Launches HOPE Therapeutics, Inc. at the BIO CEO & Investor Conference...
NRx Pharmaceuticals (Nasdaq:NRXP) to Launch HOPE Therapeutics, Inc. at the BIO CEO & Investor Conference...
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Advance of $5 Million Milestone Payment from Partners...
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Reports Comments by Strategic Partner Lotus Pharmaceutical Co. Ltd...
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces the Incorporation of HOPE Therapeutics, Inc., and Planned...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.